145 related articles for article (PubMed ID: 24921218)
1. Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma.
Sio TT; Martenson JA; Haddock MG; Novotny PJ; Gores GJ; Alberts SR; Miller RC; Heimbach JK; Rosen CB
Am J Clin Oncol; 2016 Jun; 39(3):271-5. PubMed ID: 24921218
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.
Duignan S; Maguire D; Ravichand CS; Geoghegan J; Hoti E; Fennelly D; Armstrong J; Rock K; Mohan H; Traynor O
HPB (Oxford); 2014 Jan; 16(1):91-8. PubMed ID: 23600750
[TBL] [Abstract][Full Text] [Related]
3. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
[TBL] [Abstract][Full Text] [Related]
4. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
[TBL] [Abstract][Full Text] [Related]
5. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.
De Vreede I; Steers JL; Burch PA; Rosen CB; Gunderson LL; Haddock MG; Burgart L; Gores GJ
Liver Transpl; 2000 May; 6(3):309-16. PubMed ID: 10827231
[TBL] [Abstract][Full Text] [Related]
6. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB
Semin Liver Dis; 2004 May; 24(2):201-7. PubMed ID: 15192792
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation followed by orthotopic liver transplantation in cholangiocarcinomas: the emory experience.
Marchan EM; Landry JC
J Gastrointest Oncol; 2016 Apr; 7(2):248-54. PubMed ID: 27034793
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma.
Welling TH; Feng M; Wan S; Hwang SY; Volk ML; Lawrence TS; Zalupski MM; Sonnenday CJ
Liver Transpl; 2014 Jan; 20(1):81-8. PubMed ID: 24115315
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.
Darwish Murad S; Kim WR; Harnois DM; Douglas DD; Burton J; Kulik LM; Botha JF; Mezrich JD; Chapman WC; Schwartz JJ; Hong JC; Emond JC; Jeon H; Rosen CB; Gores GJ; Heimbach JK
Gastroenterology; 2012 Jul; 143(1):88-98.e3; quiz e14. PubMed ID: 22504095
[TBL] [Abstract][Full Text] [Related]
12. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.
Mukewar S; Gupta A; Baron TH; Gores G; Furutani K; Haddock MG; Hallemeier CL
Endoscopy; 2015 Oct; 47(10):878-83. PubMed ID: 25961442
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer.
Kobayashi S; Tomokuni A; Gotoh K; Takahashi H; Akita H; Marubashi S; Yamada T; Teshima T; Fukui K; Fujiwara Y; Sakon M
Eur J Surg Oncol; 2017 Apr; 43(4):763-771. PubMed ID: 28100416
[TBL] [Abstract][Full Text] [Related]
14. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
[TBL] [Abstract][Full Text] [Related]
15. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.
Ghafoori AP; Nelson JW; Willett CG; Chino J; Tyler DS; Hurwitz HI; Uronis HE; Morse MA; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):654-9. PubMed ID: 20864265
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
Loveday BPT; Knox JJ; Dawson LA; Metser U; Brade A; Horgan AM; Gallinger S; Greig PD; Moulton CA
J Surg Oncol; 2018 Feb; 117(2):213-219. PubMed ID: 29480952
[TBL] [Abstract][Full Text] [Related]
19. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.
Sudan D; DeRoover A; Chinnakotla S; Fox I; Shaw B; McCashland T; Sorrell M; Tempero M; Langnas A
Am J Transplant; 2002 Sep; 2(8):774-9. PubMed ID: 12243499
[TBL] [Abstract][Full Text] [Related]
20. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G
Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
